pd 98059 and ly 303511

pd 98059 has been researched along with ly 303511 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A	1
Cen, LP; Chiang, SW; Cui, Q; Fan, YM; Huang, Y; Lam, DS; Lin, D; Luo, JM; Pang, CP; van Rooijen, N; Zhang, XM	1

Other Studies

2 other study(ies) available for pd 98059 and ly 303511

Article	Year
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2 Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase	2013
PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. The European journal of neuroscience, 2007, Volume: 26, Issue:4 Topics: Analgesics, Non-Narcotic; Animals; Axons; Axotomy; Blotting, Western; Butadienes; Chromones; Clodronic Acid; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Immunohistochemistry; Janus Kinases; Macrophages; Morpholines; Neuroprotective Agents; Nitriles; Optic Nerve Injuries; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred F344; Retinal Ganglion Cells; Signal Transduction; STAT Transcription Factors; Tyrphostins	2007

Article

Year

A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013

PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.

The European journal of neuroscience, 2007, Volume: 26, Issue:4

Topics: Analgesics, Non-Narcotic; Animals; Axons; Axotomy; Blotting, Western; Butadienes; Chromones; Clodronic Acid; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Immunohistochemistry; Janus Kinases; Macrophages; Morpholines; Neuroprotective Agents; Nitriles; Optic Nerve Injuries; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred F344; Retinal Ganglion Cells; Signal Transduction; STAT Transcription Factors; Tyrphostins

2007